Q3 2025 Management View CEO Ramy Farid reported "very solid progress during the third quarter," highlighting total revenue of $54 million, a 54% increase from the third quarter of 2024. Software ...

Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...

Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, ...

Get exclusive insights on Certara’s Q3 2025 earnings—software growth, cautious outlook, and strategic moves. Learn what drives CERT’s future.

WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals Synergy TM, a software solution designed ...

The NJBIZ interview Joseph RippJoseph Ripp last month became president and COO of Dendrite International, succeeding Paul Zaffaroni, who retired. Ripp, 53, joined the Bedminster-based maker of sales ...

SAINT-GEORGES, QUEBEC, CANADA, February 26, 2024 / EINPresswire.com / -- BCE Pharma Software and Compounding Consultants, a Canadian leader since 2008, is proud to announce its international expansion ...

At the cutting edge of drug development, pharmacotherapy is being integrated with software, ushering in a new generation of therapies designed to treat disease more effectively: software-enhanced ...

You don't need to be clued into the expansive pharmaceutical industry to understand that it's one of the biggest and fastest growing sectors of the international market. Valued at $86 billion as of ...

Medidata accused Veeva of stealing secrets to make competing software Had asked for as much as $450 million in damages (Reuters) - Veeva Systems Inc on Friday persuaded a judge to throw out a lawsuit ...

Software giant Microsoft Corp. (www.microsoft.com), Redmond, Wash., has unveiled its Digital Pharma initiative, which encompasses a solutions framework for pharmaceutical and life sciences companes ...